Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study

Asthma is a chronic inflammatory airway disease, representing one of the most severe pathologies in developed countries. Based on a report of the World Health Organization (WHO), it affects about 300 million people worldwide. Few studies have analyzed the effects of daily life physical activity (PA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpagnano, Giovanna Elisiana, Sessa, Francesco, Scioscia, Giulia, Lacedonia, Donato, Foschino, Maria Pia, Venuti, Maria Pia, Triggiani, Antonio Ivano, Valenzano, Anna, Resta, Onofrio, Cibelli, Giuseppe, Messina, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992710/
https://www.ncbi.nlm.nih.gov/pubmed/32038267
http://dx.doi.org/10.3389/fphar.2019.01630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992710/
https://www.ncbi.nlm.nih.gov/pubmed/32038267
http://dx.doi.org/10.3389/fphar.2019.01630

Ejemplares similares